notice
Core Technology
Leading Research and Development company for the discovery of optimal novel drug candidates and repurposing of novel drugs using Orthotopic model-based clinical translational research
-
Orthotopic animal model
Accurately measures the efficacy and toxicity of anti-cancer drugs by transplanting tumors directly into the target organ
Detail View -
Clinical Translational research
Two-directional study for developing enhanced treatment methods by applying the research result or newly discovered knowledge from basic science into actual clinical research
Detail View
PRINT™
PLATBIO’s Target Discovery PLAFORM PRIINT
- PRIINT Characteristics
-
- Establish orthotopic
model for specific tumors - Tumor target discovery
and verification - Cross-checking of tumor targets using
tumor
tissues and blood
- Establish orthotopic
- PRIINT Advantages
-
- Reduce the gap between pre-clinical
stages and clinical stages - Reduce the cost and
time for novel drug development - Cost-effective development with
re-utilization of
existing clinical products subs
- Reduce the gap between pre-clinical
-
Business Model
Increase the success rate of novel drug development
Detail View
and diversify the risks from multiple business models to Increase -
Repositioning /
Re-entryMethod of developing new drugs by identifying new indications from unlicensed drugs
Detail View -
Pipeline
Continuously expand the global competitive pipeline through original research capabilities and technologies
Detail View
